EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/27/2026
Back to search
Official data from USPTO
PROPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000097718561Class
35, 42, 44, 45
Filing
97718561
Registration
7590236
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
03/29/2026
Trademark type
Combined
Nice classes
35, 42, 44, 45
Filing date
12/15/2022
Registration date
12/03/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/03/2024
Last transaction
03/29/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/09/2023
First use in commerce
01/09/2023
Drawing code
3
Owner type
16
Owner location
Raleigh, NC, US
Examiner
BECHHOFER, YOCHEVED D
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of stylized word "propharma"; the "o" in the word has varying ombre-type lines within the letter.
Holders and representatives
Holders
ProPharma Group Holdings, LLC
ProPharma Group Holdings, LLC
Representatives
Dianne M. Smith-Misemer HOVEY WILLIAMS LLP
Technical classification
Nice Classes
Class 35Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business information and business consulting servicesproviding business advisory services to identifyscreenselect contract manufacturing organizations to contract and build medical and pharmaceutical products and devices; providing business advisory services to health care providersdesigning the administrativefinancial and clinical workflows associated with value-based healthcare delivery models; providing business assistance to healthcare providers in the field of enabling communication and collaboration for the purpose of developingimplementing and evaluating patient care plans; Business servicestracking and monitoring regulatory requirements in the pharmaceuticalbiotechnologymedical fields for business purposes; maintaining files and records concerning the medical condition of individuals; maintaining personal medical history records and files
Class 42
Providing quality assurance services in the medicalpharmaceuticalbiotechnology fields; Quality management servicesquality evaluation and analysisquality assurancequality controlin the medicalpharmaceuticalbiotechnology fields; Testinganalysisevaluation of medicalpharmaceuticalbiotechnology services to assure compliance with industry standards; Tracking and monitoring regulatory requirements in the pharmaceuticalbiotechnologymedical fields for quality control purposes; consulting services in the field of biotechnology
Class 44
Medical and pharmaceutical consultation; providing medical and pharmaceutical information servicesdrug interaction call centersadverse event reporting services for drugs and medical devices and product compliant reporting services for drugs and medical device; medical information; providing medical informationconsultancy and advisory services; health care consultingaggregating clinicalclaimssocioeconomic and behavioral health data for the purpose of improving healthcare providers' evaluation of health conditions and health risks with individual patientscohorts of patientspopulations; health care consultingassessing patient and population health profiles using evidence-based medical guidelines for the purpose of improving healthcare provider treatment decisions at the point of care; providing information over a global computer network in the field of health care; providing medical informationconsultancyadvisory servicesproviding healthcare providersinsurance companieshealthcare product manufacturers with information and statistics regarding patient medication intakeschedule compliancehealth status
Class 45
Regulatory compliance consulting in the pharmaceuticalbiotechnologymedical fields; Regulatory compliance consulting in the fields of drug and device development and manufacturing; Tracking and monitoring regulatory requirements in the pharmaceuticalbiotechnologymedical fields for legal or regulatory compliance purposes; Tracking and monitoring regulatory requirements in the field of drug and device development and manufacturing for regulatory compliance purposes
Publications
History of USPTO decisions and trademark events.
32 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/27/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/27/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/27/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/23/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/23/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/23/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/23/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/23/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/03/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/03/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/10/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/10/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/23/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/15/2024
IUAF
USE AMENDMENT FILED
08/12/2024
EISU
TEAS STATEMENT OF USE RECEIVED
08/12/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/20/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/26/2023
PUBO
PUBLISHED FOR OPPOSITION
12/26/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/21/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/16/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/16/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/16/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/21/2023
GNRT
NON-FINAL ACTION E-MAILED
09/21/2023
CNRT
NON-FINAL ACTION WRITTEN
09/21/2023
DOCK
ASSIGNED TO EXAMINER
09/19/2023
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/12/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/11/2023
NWAP
NEW APPLICATION ENTERED
12/19/2022
Continuous trademark protection
Get notified about every new filing that threatens PROPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.